{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:19:24Z","timestamp":1777479564609,"version":"3.51.4"},"reference-count":60,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2018,5,29]]},"DOI":"10.3233\/cbm-181218","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T11:19:55Z","timestamp":1523618395000},"page":"351-357","source":"Crossref","is-referenced-by-count":2,"title":["No evidence of pancreatic ductal adenocarcinoma specific autoantibodies to Ezrin in a liquid phase LIPS immunoassay"],"prefix":"10.1177","volume":"22","author":[{"given":"Daniela","family":"Liberati","sequence":"first","affiliation":[{"name":"Division of Genetics and Cell Biology, Genomic Unit for the Diagnosis of Human Pathologies, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy"},{"name":"Division of Genetics and Cell Biology, Genomic Unit for the Diagnosis of Human Pathologies, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Marzinotto","sequence":"additional","affiliation":[{"name":"Division of Genetics and Cell Biology, Genomic Unit for the Diagnosis of Human Pathologies, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy"},{"name":"Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy"},{"name":"Division of Genetics and Cell Biology, Genomic Unit for the Diagnosis of Human Pathologies, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Brigatti","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Dugnani","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Pasquale","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Reni","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianpaolo","family":"Balzano","sequence":"additional","affiliation":[{"name":"Pancreatic Surgery Unit, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy"},{"name":"Vita-Salute San Raffaele University, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Falconi","sequence":"additional","affiliation":[{"name":"Pancreatic Surgery Unit, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy"},{"name":"Vita-Salute San Raffaele University, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Piemonti","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy"},{"name":"Vita-Salute San Raffaele University, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Lampasona","sequence":"additional","affiliation":[{"name":"Division of Genetics and Cell Biology, Genomic Unit for the Diagnosis of Human Pathologies, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"5","key":"10.3233\/CBM-181218_ref1","doi-asserted-by":"crossref","first-page":"v56","DOI":"10.1093\/annonc\/mdv295","article-title":"and ESMO Guidelines Committee, Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Ducreux","year":"2015","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.3233\/CBM-181218_ref2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbcan.2014.12.001","article-title":"Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic","volume":"1855","author":"Fokas","year":"2015","journal-title":"Biochim Biophys Acta\u00a0\u2013 Rev Cancer"},{"key":"10.3233\/CBM-181218_ref3","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1200\/JCO.2014.59.7930","article-title":"Approach to patients with pancreatic cancer without detectable metastases","volume":"33","author":"Heestand","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.3233\/CBM-181218_ref4","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMra0901557","article-title":"Pancreatic cancer","volume":"362","author":"Hidalgo","year":"2010","journal-title":"N Engl J Med"},{"key":"10.3233\/CBM-181218_ref5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.seminoncol.2014.12.002","article-title":"Demographics, epidemiology and inheritance of pancreatic ductal adenocarcinoma","volume":"42","author":"Yeo","year":"2015","journal-title":"Semin Oncol"},{"key":"10.3233\/CBM-181218_ref6","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00415-016-8090-7","article-title":"Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes","volume":"263","author":"Storstein","year":"2016","journal-title":"J Neurol"},{"key":"10.3233\/CBM-181218_ref7","first-page":"4","article-title":"Therapeutic approaches in antibody-associated central nervous system pathologies","author":"Honnorat","year":"2014","journal-title":"Rev Neurol (Paris)"},{"key":"10.3233\/CBM-181218_ref8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","article-title":"Antibodies and neuronal autoimmune disorders of the CNS","volume":"257","author":"Graus","year":"2010","journal-title":"J Neurol"},{"key":"10.3233\/CBM-181218_ref9","doi-asserted-by":"crossref","unstructured":"K. Dumstrei, H. Chen and H. Brenner, A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection, Oncotarget 7 (2016).","DOI":"10.18632\/oncotarget.7098"},{"key":"10.3233\/CBM-181218_ref10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1756-8722-6-67","article-title":"Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models","volume":"6","author":"Capello","year":"2013","journal-title":"J Hematol Oncol"},{"key":"10.3233\/CBM-181218_ref11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10552-016-0757-y","article-title":"A prospective study of autoantibodies to Ezrin and pancreatic cancer risk","volume":"27","author":"Sun","year":"2016","journal-title":"Cancer Causes Control"},{"key":"10.3233\/CBM-181218_ref12","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/clinchem\/47.9.1729","article-title":"Detection of anti-survivin antibody in gastrointestinal cancer patients","volume":"47","author":"Yagihashi","year":"2001","journal-title":"Clin Chem"},{"key":"10.3233\/CBM-181218_ref13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/CBM-2010-0145","article-title":"The identification of auto-antibodies in pancreatic cancer patient sera using a naturally fractionated Panc-1 cell line","volume":"7","author":"Li","year":"2010","journal-title":"Cancer Biomark"},{"key":"10.3233\/CBM-181218_ref14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-3083.2011.02657.x","article-title":"Immunodiagnostic Value of Combined Detection of Autoantibodies to Tumor-associated Antigens as Biomarkers in Pancreatic Cancer","volume":"75","author":"Li","year":"2012","journal-title":"Scand J Immunol"},{"key":"10.3233\/CBM-181218_ref15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bbrc.2005.02.181","article-title":"Proteomics-based identification of DEAD-box protein 48 as a novel autoantigen, a prospective serum marker for pancreatic cancer","volume":"330","author":"Xia","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/CBM-181218_ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0162502","article-title":"Ezrin is associated with disease progression in ovarian carcinoma","volume":"11","author":"Horwitz","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/CBM-181218_ref17","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.12659\/MSM.904124","article-title":"Interaction Between Ezrin and Cortactin in Promoting Epithelial to Mesenchymal Transition in Breast Cancer Cells","volume":"23","author":"He","year":"2017","journal-title":"Med Sci Monit"},{"key":"10.3233\/CBM-181218_ref18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1479-5876-8-61","article-title":"Ezrin promotes invasion and metastasis of pancreatic cancer cells","volume":"8","author":"Meng","year":"2010","journal-title":"J Transl Med"},{"key":"10.3233\/CBM-181218_ref19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jso.20654","article-title":"Adhesion molecules as prognostic markers in pancreatic adenocarcinoma","volume":"96","author":"Torer","year":"2007","journal-title":"J Surg Oncol"},{"key":"10.3233\/CBM-181218_ref20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/030089160909500113","article-title":"Expression of ezrin and metastatic tumor antigen in osteosarcomas of the jaw","volume":"95","author":"Park","year":"2009","journal-title":"Tumori"},{"key":"10.3233\/CBM-181218_ref21","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrc1298","article-title":"Diet and cancer\u00a0\u2013 the european prospective investigation into cancer and nutrition","volume":"4","author":"Bingham","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.3233\/CBM-181218_ref22","doi-asserted-by":"crossref","unstructured":"E. Liu and G.S. Eisenbarth, Accepting clocks that tell time poorly: Fluid-phase versus standard ELISA autoantibody assays, Clin Immunol 125 (2007),120\u20136.","DOI":"10.1016\/j.clim.2007.08.005"},{"key":"10.3233\/CBM-181218_ref23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1006\/jaut.1994.1051","article-title":"Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on western blots but do not immunoprecipitate liquid phase antigen","volume":"7","author":"Lampasona","year":"1994","journal-title":"J Autoimmun"},{"key":"10.3233\/CBM-181218_ref24","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1212\/01.WNL.0000127615.15768.AE","article-title":"Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects","volume":"62","author":"Lampasona","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/CBM-181218_ref25","doi-asserted-by":"crossref","unstructured":"I. Marzinotto, D. Liberati, C. Brigatti, R. Bonfanti, A. Stabilini, P. Monti, E. Bosi, L. Piemonti and V. Lampasona, Autoantibody binding in liquid phase to IL-2 in human sera is not type 1 diabetes specific, (2017), 125\u2013126.","DOI":"10.1007\/s00125-017-4376-2"},{"key":"10.3233\/CBM-181218_ref26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1472-6750-5-22","article-title":"A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins","volume":"5","author":"Burbelo","year":"2005","journal-title":"BMC Biotechnol"},{"key":"10.3233\/CBM-181218_ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2007.11.077","article-title":"High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65\/GAD67 in stiff-person syndrome","volume":"366","author":"Burbelo","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/CBM-181218_ref28","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.2337\/dc08-0286","article-title":"A new luminescence assay for autoantibodies to mammalian cell\u00a0\u2013 prepared insulinoma-associated protein 2","volume":"31","author":"Burbelo","year":"2008","journal-title":"Diabetes Care"},{"key":"10.3233\/CBM-181218_ref29","doi-asserted-by":"crossref","first-page":"e78664","DOI":"10.1371\/journal.pone.0078664","article-title":"Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome","volume":"8","author":"Lampasona","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/CBM-181218_ref30","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.2337\/db15-1058","article-title":"Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes","volume":"65","author":"McLaughlin","year":"2016","journal-title":"Diabetes"},{"key":"10.3233\/CBM-181218_ref31","doi-asserted-by":"crossref","unstructured":"D. Liberati, R.C. Wyatt, C. Brigatti, I. Marzinotto, M. Ferrari, E. Bazzigaluppi, E. Bosi, B.T. Gillard, K.M. Gillespie, F. Gorus, I. Weets, E. Balti, L. Piemonti, P. Achenbach, A.J.K. Williams and V. Lampasona, A novel LIPS assay for insulin autoantibodies, Acta Diabetol (2018).","DOI":"10.1007\/s00592-017-1082-y"},{"key":"10.3233\/CBM-181218_ref32","doi-asserted-by":"crossref","unstructured":"World Health Organisation, Declaration of helsinki world medical association declaration of helsinki ethical principles for medical research involving human subjects, J Am Med Assoc 310 (2013), 2191\u20132194.","DOI":"10.1001\/jama.2013.281053"},{"key":"10.3233\/CBM-181218_ref33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jim.2006.06.003","article-title":"Non-specific binding to protein A Sepharose and protein G Sepharose in insulin autoantibody assays may be reduced by pre-treatment with glycine or ethanolamine","volume":"314","author":"Williams","year":"2006","journal-title":"J Immunol Methods"},{"key":"10.3233\/CBM-181218_ref34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1006\/jaut.1997.0154","article-title":"A novel micro-assay for insulin autoantibodies","volume":"10","author":"Williams","year":"1997","journal-title":"J Autoimmun"},{"key":"10.3233\/CBM-181218_ref35","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/WCO.0b013e328359da15","article-title":"Paraneoplastic neurological syndromes","volume":"25","author":"Graus","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.3233\/CBM-181218_ref36","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/CBM-181218_ref37","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/cei.12185","article-title":"Paraneoplastic neurological syndromes","volume":"175","author":"Leypoldt","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.3233\/CBM-181218_ref38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1172-2-22","article-title":"Paraneoplastic neurological syndromes","volume":"2","author":"Honnorat","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.3233\/CBM-181218_ref39","first-page":"1815","article-title":"Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients advances in brief antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients 1","author":"Rohayem","year":"2000","journal-title":"Cancer"},{"key":"10.3233\/CBM-181218_ref40","first-page":"136","article-title":"Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens","volume":"12","author":"Zhang","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.3233\/CBM-181218_ref41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.lungcan.2004.11.002","article-title":"Detection of autoantibodies to livin and survivin in sera from lung cancer patients","volume":"48","author":"Yagihashi","year":"2005","journal-title":"Lung Cancer"},{"key":"10.3233\/CBM-181218_ref42","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s13277-014-2756-5","article-title":"Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer","volume":"36","author":"Liu","year":"2015","journal-title":"Tumour Biol"},{"key":"10.3233\/CBM-181218_ref43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/clim.2001.5048","article-title":"Autoimmune responses to mRNA binding proteins p62 and Koc in diverse malignancies","volume":"100","author":"Zhang","year":"2001","journal-title":"Clin Immunol"},{"key":"10.3233\/CBM-181218_ref44","first-page":"5120","article-title":"Recursive partitioning as an approach to selection of immune markers for tumor diagnosis","volume":"9","author":"Koziol","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.3233\/CBM-181218_ref45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mge.2003.28","article-title":"Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds","volume":"57","author":"Rulyak","year":"2003","journal-title":"Gastrointest Endosc"},{"key":"10.3233\/CBM-181218_ref46","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.gastro.2005.05.007","article-title":"Probability of pancreatic cancer following diabetes: A population-based study","volume":"129","author":"Chari","year":"2005","journal-title":"Gastroenterology"},{"key":"10.3233\/CBM-181218_ref47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-1759(12)80037-8","article-title":"Caveats for the use of surface-adsorbed protein antigen to test the specificity of antibodies","volume":"147","author":"Schwab","year":"1992","journal-title":"J Immunol Methods"},{"key":"10.3233\/CBM-181218_ref48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0022-1759(93)90223-T","article-title":"Protein A antibody-capture ELISA (PACE): An ELISA format to avoid denaturation of surface-adsorbed antigens","volume":"158","author":"Ngai","year":"1993","journal-title":"J Immunol Methods"},{"key":"10.3233\/CBM-181218_ref49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/pro.5560020206","article-title":"Mapping antibody binding sites on cytochrome c with synthetic peptides: Are results representative of the antigenic structure of proteins?","volume":"2","author":"Schwab","year":"1993","journal-title":"Protein Sci"},{"key":"10.3233\/CBM-181218_ref50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1432-1033.1994.tb19916.x","article-title":"Genuine and apparent cross-reaction of polyclonal antibodies to proteins and peptides","volume":"219","author":"Leder","year":"1994","journal-title":"Eur J Biochem"},{"key":"10.3233\/CBM-181218_ref51","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00018-011-0872-6","article-title":"Polyreactive antibodies in adaptive immune responses to viruses","volume":"69","author":"Mouquet","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/CBM-181218_ref52","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.it.2004.02.004","article-title":"Polyreactivity of antibody molecules","volume":"25","author":"Notkins","year":"2004","journal-title":"Trends Immunol"},{"key":"10.3233\/CBM-181218_ref53","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/BF00418550","article-title":"Islet cell autoantigen 69 antibodies in IDDM","volume":"39","author":"Martin","year":"1996","journal-title":"Diabetologia"},{"key":"10.3233\/CBM-181218_ref54","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1111\/j.1464-5491.2005.01756.x","article-title":"No evidence of diabetes-specific CD38 (ADP ribosil cyclase\/cyclic ADP-ribose hydrolase), autoantibodies by liquid-phase immunoprecipitation","volume":"22","author":"Sordi","year":"2005","journal-title":"Diabet Med"},{"key":"10.3233\/CBM-181218_ref55","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1056\/NEJM199312163292505","article-title":"Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes","volume":"329","author":"Atkinson","year":"1993","journal-title":"N Engl J Med"},{"key":"10.3233\/CBM-181218_ref56","doi-asserted-by":"crossref","unstructured":"A.G. Ziegler, U. Mollenhauer, P. Achenbach and E. Bonifacio, Anti-CCL3 autoantibodies are not markers of type 1 diabetes when measured by a commercial ELISA method, Diabetologia (2010).","DOI":"10.1007\/s00125-010-1976-5"},{"key":"10.3233\/CBM-181218_ref57","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm1488","article-title":"Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein","volume":"13","author":"O\u2019Connor","year":"2007","journal-title":"Nat Med"},{"key":"10.3233\/CBM-181218_ref58","first-page":"1040","article-title":"Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: Results of the Fourth International Workshop on the Standardization of Insuli","volume":"74","author":"Greenbaum","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3233\/CBM-181218_ref59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jim.2010.09.009","article-title":"Anti-BSA antibodies are a major cause of non-specific binding in insulin autoantibody radiobinding assays","volume":"362","author":"Williams","year":"2010","journal-title":"J Immunol Methods"},{"key":"10.3233\/CBM-181218_ref60","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/BF00401430","article-title":"Disease-associated anti-bovine serum albumin antibodies in Type 1 (insulin-dependent) diabetes mellitus are detected by particle concentration fluoroimmunoassay, and not by enzyme linked immunoassay","volume":"35","author":"Karjalainen","year":"1992","journal-title":"Diabetologia"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-181218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:06:05Z","timestamp":1777385165000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-181218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,29]]},"references-count":60,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/cbm-181218","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5,29]]}}}